Value of Tc-99m Renography for Early Diagnosis of Cisplatin-induced Renal Toxicity
N/A
18 Years
80 Years
18 Years
80 Years
Not Enrolling
Both
Cancer, Drug Toxicity, Kidney Failure
Both
Cancer, Drug Toxicity, Kidney Failure
Trial Information
Value of Tc-99m Renography for Early Diagnosis of Cisplatin-induced Renal Toxicity
Inclusion Criteria:
- Patients with head and neck cancer
- Receiving a chemotherapy including cisplatin administration (>80 mg/m2)
- WHO score < or = 2
- Estimated life expectancy > 6 month
- Normal renal function
- Signed informed consent
Exclusion Criteria:
- Congestive heart failure
- History of cisplatin treatment
- Metastatic carcinoma
- History of radiation therapy
- History of renal insufficiency
- History of chronic renal disease
- Pregnancy
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Alain Manrique, MD
Investigator Role:
Study Chair
Investigator Affiliation:
University Hospital, Rouen
Authority:
France: Ministry of Health
Study ID:
2000/003/HP
NCT ID:
NCT00213642
Start Date:
July 2001
Completion Date:
August 2004
Related Keywords:
- Cancer
- Drug Toxicity
- Kidney Failure
- Technetium Tc 99m Mertiatide
- Radionuclide Imaging
- Cisplatin
- Kidney failure
- Drug Toxicity
- Cancer
- Drug Toxicity
- Renal Insufficiency
Name | Location |
|---|
